Law360, New York (August 30, 2017, 12:30 PM EDT) -- The courts in recent years have handed the U.S. Department of Justice and the U.S. Food and Drug Administration a string of defeats in cases involving government efforts to prosecute companies and individuals for so-called off-label promotion. While many hoped that these rulings would usher in an era where companies could safely engage in truthful and nonmisleading discussions without fear of enforcement, a review of recent government activity suggests that the government remains committed to aggressively pursuing off-label cases, even if limited to using civil remedies.
The takeaway from recent settlements is that promotional activities continue to be a significant compliance...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!